Optimizing Outcomes for Patients With Advanced Disease in Chronic Myelogenous Leukemia
To access this article, please choose from the options below
PII: S0093-7754(07)00271-0
doi:10.1053/j.seminoncol.2007.12.002
© 2008 Elsevier Inc. All rights reserved.
